| May 29, 2013
| 3:18 PM
The Food and Drug Administration on Wednesday announced its approval of two new drugs and a diagnostic test that can be used to treat advanced or inoperable melanoma, the most dangerous form of skin disease.
Advanced melanoma has joined a wide range...
| May 19, 2013
| 8:22 AM
WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...
| Apr 21, 2013
After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound.
But the failed experimental drug, called GW501516, is making a comeback in another...
| Mar 19, 2013
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines.
Today, as the world confronts the crisis of antibiotic resistance, the industry...
| Feb 20, 2013
| 3:50 PM
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market.
The company also withheld data that showed the drugs...
| Feb 10, 2013
If co-workers and family members are coming down with infections this winter, you may be tempted to turn to an anti-bacterial soap for protection.
But some scientists are increasingly concerned that a common anti-bacterial ingredient called triclosan...
| Oct 17, 2012
| 3:19 PM
Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
| Sep 5, 2012
| 12:45 PM
Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline.
Human Genome, which employs about 1,000 people in Rockville, could...
| Sep 4, 2012
| 4:05 PM
LONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday.
In new advice about...
| Aug 10, 2012
Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle.
Such a person would have "maybe some stomach problem, but not die," he told...
| Jul 18, 2012
| 11:43 AM
LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.
The United Nations...